Key facts
- It has raised $1.3M; the latest was Seed Round ($1.1M) in Sep 2025.
- Notable investors include US National Science Foundation, Science Center, The Innovation Space.
- Robossis has filed 2 Form Ds with the SEC, most recently Sep 2025 ($150K sold to 1 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Robossis
- ·The full record, as it builds
Funding rounds
No funding rounds for Robossis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Robossis
Manufacturer of a robotic surgery device designed to assist surgeons with pre-operative planning and alignment of long bone fractures. The company's surgery device uses imaging software connected to an X-ray machine and integrated into the robot to provide a three-dimensional image of the leg, enabling surgeons to get a clear picture of the break and visualize the optimum path of the robot to follow, leading to fast, efficient, and risk-free surgeries.
- Sector
- Healthcare
- HQ
- Camden, NJ, United States
- Founded
- 2017
- Employees
- 9
- Website
- robossis.com/
- Ownership
- Privately Held (backing)
Robossis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Robossis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Robossis in its N-PORT filings yet. We sweep new filings monthly.